Literature DB >> 29801690

Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement.

Robert B Hawkins1, J Hunter Mehaffey1, Abra Guo1, Eric J Charles1, Alan M Speir2, Jeffrey B Rich3, Mohammed A Quader4, Gorav Ailawadi1, Leora T Yarboro5.   

Abstract

BACKGROUND: Postoperative atrial fibrillation (POAF) is a known risk factor for morbidity and mortality after cardiac surgery but has not been investigated in the left ventricular assist device (LVAD) population. We hypothesize that POAF will increase morbidity and resource utilization after LVAD placement.
METHODS: Records were extracted for all patients in a regional database who underwent continuous-flow LVAD placement (n = 1064, 2009-2017). Patients without a history of atrial fibrillation (n = 689) were stratified by POAF for univariate analysis. Multivariable regression models calculated the risk-adjusted association of arrhythmias on outcomes and resource utilization.
RESULTS: The incidence of new-onset POAF was 17.6%, and patients who developed POAF were older and more likely to have moderate/severe mitral regurgitation, a history of stroke, and concomitant tricuspid surgery. After risk adjustment, POAF was not associated with operative mortality or stroke but was associated with major morbidity (odds ratio [OR] 2.5 P = .0004), prolonged ventilation (OR 2.7, P < .0001), unplanned right ventricular assist device (OR 2.9, P = .01), and a trend toward renal failure (OR 2.0, P = .06). In addition, POAF was associated with greater risk-adjusted resource utilization, including discharge to a facility (OR 2.2, P = .007), an additional 4.9 postoperative days (P = .02), and 88 hours in the intensive care unit (P = .01).
CONCLUSIONS: POAF was associated with increased major morbidity, possibly from worsening right heart failure leading to increased renal failure and unplanned right ventricular assist device placement. This led to patients with POAF having longer intensive care unit and hospital stays and more frequent discharges to a facility.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; cost; resource utilization; ventricular assist device

Mesh:

Year:  2018        PMID: 29801690      PMCID: PMC6156995          DOI: 10.1016/j.jtcvs.2018.03.169

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  26 in total

1.  Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.

Authors:  J P Mathew; R Parks; J S Savino; A S Friedman; C Koch; D T Mangano; W S Browner
Journal:  JAMA       Date:  1996 Jul 24-31       Impact factor: 56.272

2.  Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.

Authors:  Rashmi U Hottigoudar; Allen G Deam; Emma J Birks; Kelly C McCants; Mark S Slaughter; Rakesh Gopinathannair
Journal:  Congest Heart Fail       Date:  2013 Jul-Aug

Review 3.  Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.

Authors:  Finn Gustafsson; Joseph G Rogers
Journal:  Eur J Heart Fail       Date:  2017-02-15       Impact factor: 15.534

4.  Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia.

Authors:  Alan M Speir; Vigneshwar Kasirajan; Scott D Barnett; Edwin Fonner
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

5.  Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices.

Authors:  Meredith A Brisco; Kartik S Sundareswaran; Carmelo A Milano; David Feldman; Jeffrey M Testani; Gregory A Ewald; Mark S Slaughter; David J Farrar; Lee R Goldberg
Journal:  J Card Surg       Date:  2014-04-18       Impact factor: 1.620

6.  The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery.

Authors:  Dimitri Kalavrouziotis; Karen J Buth; Imtiaz S Ali
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

7.  Permanent Atrial Fibrillation and 2 Year Clinical Outcomes in Patients with a Left Ventricular Assist Device Implant.

Authors:  Cenk Oezpeker; Armin Zittermann; Thomas Pühler; Stephan Ensminger; Jan F Gummert; Michiel Morshuis
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

8.  Impact of Preoperative Atrial Fibrillation on Postoperative Thromboembolic Events After Left Ventricular Assist Device Implantation.

Authors:  Linnea Xuereb; Pauline H Go; Babbaljeet Kaur; Silvy Akrawe; Hassan W Nemeh; Jamil Borgi; Celeste T Williams; Gaetano Paone; Jeffrey A Morgan
Journal:  Ann Thorac Surg       Date:  2016-07-25       Impact factor: 4.330

9.  Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs.

Authors:  Damien J LaPar; Alan M Speir; Ivan K Crosby; Edwin Fonner; Michael Brown; Jeffrey B Rich; Mohammed Quader; John A Kern; Irving L Kron; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2014-08       Impact factor: 4.330

Review 10.  Post-operative atrial fibrillation: a maze of mechanisms.

Authors:  Bart Maesen; Jan Nijs; Jos Maessen; Maurits Allessie; Ulrich Schotten
Journal:  Europace       Date:  2011-08-06       Impact factor: 5.214

View more
  4 in total

1.  Clinical impact of newly developed atrial fibrillation complicated with longstanding ventricular fibrillation during left ventricular assist device support: A case report.

Authors:  Chie Bujo; Eisuke Amiya; Masaru Hatano; Masaki Tsuji; Hisataka Maki; Yumiko Hosoya; Emi Fujii; Tatsuya Kamon; Toshiya Kojima; Kan Nawata; Osamu Kinoshita; Mitsutoshi Kimura; Minoru Ono; Issei Komuro
Journal:  BMC Cardiovasc Disord       Date:  2019-06-21       Impact factor: 2.298

2.  MiRNA-1202 promotes the TGF-β1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.

Authors:  Jingwen Xiao; Yan Zhang; Yuan Tang; Hengfen Dai; Yu OuYang; Chuanchuan Li; Meiqin Yu
Journal:  PLoS One       Date:  2021-08-24       Impact factor: 3.240

Review 3.  Atrial arrhythmias in patients with left ventricular assist devices.

Authors:  Cevher Ozcan; Amrish Deshmukh
Journal:  Curr Opin Cardiol       Date:  2020-05       Impact factor: 2.108

Review 4.  Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function.

Authors:  Bianca-Ana Dmour; Radu-Stefan Miftode; Dan Iliescu Halitchi; Dana Teodora Anton-Paduraru; Codruta-Olimpiada Iliescu Halitchi; Ionela-Larisa Miftode; Ovidiu Mitu; Alexandru-Dan Costache; Celina-Silvia Stafie; Irina Iuliana Costache
Journal:  Diagnostics (Basel)       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.